The UK’s MedTech Directorate is pressing ahead with 16 separate initiatives under its recently issued medtech strategy. It all adds to the sense that 2023 will be a major year for UK medtech.
“Right product, right price, right place” is the triple goal that the UK MedTech Directorate (MTD) is intent on achieving for UK providers and patients in the first ever UK strategy for medtech.
An implementation plan is to be developed by June, MTD director David Lawson told a public online meeting. It will...
The new AI Precision Medicine platform supports the company’s flagship product, EvoLiver, which received US FDA breakthrough device designation in April.
Experts at the Prix Galien UK Forum discussed the future of mental health innovation, emphasizing the important roles of digital solutions, diagnostic biomarkers and community involvement.
After two serious injuries and one death linked to some of its ventilators, Medtronic has recalled the devices and asked customers to stop using them and find alternative means. The action comes more than a year after the company left the market.
Market access concerns dominated at the annual BioWales In London event, where AstraZeneca set out industry’s priorities and the UK Office for Life Sciences struck an optimistic tone about how the UK will lastingly improve uptake of innovation.
